Cargando…

Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study

BACKGROUND: No previous studies have examined the possible relationship between intraductal papillary mucinous neoplasm (IPMN) and the developmental ductal variations of the pancreas, such as an ansa pancreatica and a meandering main pancreatic duct (MMPD). METHODS: This retrospective cross-sectiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Katarina, Mustonen, Harri, Seppänen, Hanna, Lehtimäki, Tiina E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394057/
https://www.ncbi.nlm.nih.gov/pubmed/35989322
http://dx.doi.org/10.1186/s12876-022-02465-w
_version_ 1784771405743652864
author Johansson, Katarina
Mustonen, Harri
Seppänen, Hanna
Lehtimäki, Tiina E.
author_facet Johansson, Katarina
Mustonen, Harri
Seppänen, Hanna
Lehtimäki, Tiina E.
author_sort Johansson, Katarina
collection PubMed
description BACKGROUND: No previous studies have examined the possible relationship between intraductal papillary mucinous neoplasm (IPMN) and the developmental ductal variations of the pancreas, such as an ansa pancreatica and a meandering main pancreatic duct (MMPD). METHODS: This retrospective cross-sectional study enrolled 214 patients, 108 with IPMN disease and 106 subjects from a community at the tertiary care unit. The main pancreatic duct (MPD) was evaluated in the head of the pancreas by its course, which were non-MMPD: descending, vertical, and sigmoid, or MMPD including loop types, reverse-Z subtypes, and an N-shape, which was identified for the first time in this study. IPMN patients were also evaluated for worrisome features (WF) or high-risk stigmata (HRS), and the extent of IPMN cysts. RESULTS: Among IPMN patients, 18.4% had MMPD, which we observed in only 3.0% of the control group (P < 0.001). Patients with MMPD were more likely to belong to the IPMN group compared with non-MMPD patients [odds ratio (OR) 6.4, 95% confidence interval (CI) 2.2–24.9]. Compared with a descending shape MPD, IPMN patients with an N-shaped MPD were more likely to have a cystic mural nodule (OR 5.9, 95% CI 1.02–36.0). The presence of ansa pancreatica associated with more extent IPMN disease (OR 12.8, 95% CI 2.6–127.7). CONCLUSIONS: IPMN patients exhibited an MMPD more often than control patients. Ansa pancreatica associated with multiple cysts. Furthermore, an N-shape in IPMN patients associated with cystic mural nodules, suggesting that this shape serves as a risk factor for more severe IPMN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02465-w.
format Online
Article
Text
id pubmed-9394057
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93940572022-08-23 Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study Johansson, Katarina Mustonen, Harri Seppänen, Hanna Lehtimäki, Tiina E. BMC Gastroenterol Research BACKGROUND: No previous studies have examined the possible relationship between intraductal papillary mucinous neoplasm (IPMN) and the developmental ductal variations of the pancreas, such as an ansa pancreatica and a meandering main pancreatic duct (MMPD). METHODS: This retrospective cross-sectional study enrolled 214 patients, 108 with IPMN disease and 106 subjects from a community at the tertiary care unit. The main pancreatic duct (MPD) was evaluated in the head of the pancreas by its course, which were non-MMPD: descending, vertical, and sigmoid, or MMPD including loop types, reverse-Z subtypes, and an N-shape, which was identified for the first time in this study. IPMN patients were also evaluated for worrisome features (WF) or high-risk stigmata (HRS), and the extent of IPMN cysts. RESULTS: Among IPMN patients, 18.4% had MMPD, which we observed in only 3.0% of the control group (P < 0.001). Patients with MMPD were more likely to belong to the IPMN group compared with non-MMPD patients [odds ratio (OR) 6.4, 95% confidence interval (CI) 2.2–24.9]. Compared with a descending shape MPD, IPMN patients with an N-shaped MPD were more likely to have a cystic mural nodule (OR 5.9, 95% CI 1.02–36.0). The presence of ansa pancreatica associated with more extent IPMN disease (OR 12.8, 95% CI 2.6–127.7). CONCLUSIONS: IPMN patients exhibited an MMPD more often than control patients. Ansa pancreatica associated with multiple cysts. Furthermore, an N-shape in IPMN patients associated with cystic mural nodules, suggesting that this shape serves as a risk factor for more severe IPMN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02465-w. BioMed Central 2022-08-21 /pmc/articles/PMC9394057/ /pubmed/35989322 http://dx.doi.org/10.1186/s12876-022-02465-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Johansson, Katarina
Mustonen, Harri
Seppänen, Hanna
Lehtimäki, Tiina E.
Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title_full Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title_fullStr Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title_full_unstemmed Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title_short Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
title_sort anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394057/
https://www.ncbi.nlm.nih.gov/pubmed/35989322
http://dx.doi.org/10.1186/s12876-022-02465-w
work_keys_str_mv AT johanssonkatarina anatomicalpancreaticvariantsinintraductalpapillarymucinousneoplasmpatientsacrosssectionalstudy
AT mustonenharri anatomicalpancreaticvariantsinintraductalpapillarymucinousneoplasmpatientsacrosssectionalstudy
AT seppanenhanna anatomicalpancreaticvariantsinintraductalpapillarymucinousneoplasmpatientsacrosssectionalstudy
AT lehtimakitiinae anatomicalpancreaticvariantsinintraductalpapillarymucinousneoplasmpatientsacrosssectionalstudy